Scott A. Gangloff

Insider Reports History

Entity
Individual
Location
C/O Oncobiologics, Inc., 7 Clarke Drive, Cranbury, NJ
Signature
/s/ Jonathan Young, Attorney-in-Fact
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Scott A. Gangloff:

Stock Role Class Num Shares Value Price $ Report Date Ownership
Akero Therapeutics, Inc. Chief Technology Officer Common Stock 24.3K $756K $31.10 Dec 16, 2024 Direct
Akero Therapeutics, Inc. Chief Technology Officer Stock Option (Right to Buy) 73.7K Dec 16, 2024 Direct

Insider Reports Filed by Scott A. Gangloff

Symbol Company Period Transactions Value $ Form Type Date Filed Role
AKRO Akero Therapeutics, Inc. Dec 16, 2024 2 $0 4 Dec 18, 2024 Chief Technology Officer
AKRO Akero Therapeutics, Inc. Apr 29, 2024 1 $0 4 May 1, 2024 Chief Technology Officer
AKRO Akero Therapeutics, Inc. Apr 29, 2024 0 $0 3 May 1, 2024 Chief Technology Officer